Mitosol FDA Approval History
FDA Approved: Yes (First approved February 7, 2012)
Brand name: Mitosol
Generic name: mitomycin
Dosage form: Ophthalmic Solution
Company: Mobius Therapeutics, LLC
Treatment for: Glaucoma Surgery
Mitosol (mitomycin) is an antimetabolite indicated as an adjunct to ab externo glaucoma surgery.
Development timeline for Mitosol
|Feb 9, 2012||Approval Mobius Therapeutics Receives Final FDA Approval for New Glaucoma Drug Mitosol|
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.